Health Canada
- Status: approved
🇨🇦 TIVA - Neostigmine 30 in Canada
TIVA - Neostigmine 30 (TIVA - Neostigmine 30) regulatory status in Canada.
Marketing authorisation
TIVA - Neostigmine 30 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is TIVA - Neostigmine 30 approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for TIVA - Neostigmine 30 in Canada?
Pontificia Universidade Catolica de Sao Paulo is the originator. The local marketing authorisation holder may differ — check the official source linked above.